Abstract
Angiotensin II (Ang II) participates in the progression of chronic kidney disease through the activation of several signaling pathways, such as calcium mobilization and activation of protein kinases, activator protein-1 (AP-1) and nuclear factor kB (NF-kB). Once activated, NF-kB controls the gene expression of several pro-inflammatory agents, increasing the expression of monocyte chemoatt…